Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 26957 | 198 | 30.4 | 42% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | INSERM E9912 | Address | 3 | 60% | 2% | 3 |
| 2 | ZK 91587 | Author keyword | 2 | 67% | 1% | 2 |
| 3 | LIALH4 REDUCTION | Author keyword | 2 | 43% | 2% | 3 |
| 4 | 1 4 6 CHOLESTATRIEN 3 ONE | Author keyword | 1 | 100% | 1% | 2 |
| 5 | ANTIMINERALOCORTICOIDS | Author keyword | 1 | 50% | 1% | 2 |
| 6 | CAS 87952 98 5 | Author keyword | 1 | 100% | 1% | 2 |
| 7 | RU 26752 | Author keyword | 1 | 50% | 1% | 2 |
| 8 | SIMMONS SMITH ADDITION | Author keyword | 1 | 100% | 1% | 2 |
| 9 | SPIRO STEROIDS | Author keyword | 1 | 100% | 1% | 2 |
| 10 | U9912 | Address | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ZK 91587 | 2 | 67% | 1% | 2 | Search ZK+91587 | Search ZK+91587 |
| 2 | LIALH4 REDUCTION | 2 | 43% | 2% | 3 | Search LIALH4+REDUCTION | Search LIALH4+REDUCTION |
| 3 | 1 4 6 CHOLESTATRIEN 3 ONE | 1 | 100% | 1% | 2 | Search 1+4+6+CHOLESTATRIEN+3+ONE | Search 1+4+6+CHOLESTATRIEN+3+ONE |
| 4 | ANTIMINERALOCORTICOIDS | 1 | 50% | 1% | 2 | Search ANTIMINERALOCORTICOIDS | Search ANTIMINERALOCORTICOIDS |
| 5 | CAS 87952 98 5 | 1 | 100% | 1% | 2 | Search CAS+87952+98+5 | Search CAS+87952+98+5 |
| 6 | RU 26752 | 1 | 50% | 1% | 2 | Search RU+26752 | Search RU+26752 |
| 7 | SIMMONS SMITH ADDITION | 1 | 100% | 1% | 2 | Search SIMMONS+SMITH+ADDITION | Search SIMMONS+SMITH+ADDITION |
| 8 | SPIRO STEROIDS | 1 | 100% | 1% | 2 | Search SPIRO+STEROIDS | Search SPIRO+STEROIDS |
| 9 | SPIROLACTONES | 1 | 19% | 3% | 5 | Search SPIROLACTONES | Search SPIROLACTONES |
| 10 | VARIABLE MAPPING | 1 | 40% | 1% | 2 | Search VARIABLE+MAPPING | Search VARIABLE+MAPPING |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SPIROLACTONE DERIVATIVES | 6 | 71% | 3% | 5 |
| 2 | ALDOSTERONE ANTAGONISTS | 3 | 32% | 5% | 9 |
| 3 | ACTIVATED MINERALOCORTICOID RECEPTOR | 3 | 100% | 2% | 3 |
| 4 | ANTIMINERALOCORTICOIDS | 2 | 67% | 1% | 2 |
| 5 | CANRENOATE K | 2 | 67% | 1% | 2 |
| 6 | SPIRORENONE | 1 | 100% | 1% | 2 |
| 7 | 21 MESYLATE ANTIGLUCOCORTICOID ACTION | 1 | 50% | 1% | 1 |
| 8 | 5 ANDROSTENE | 1 | 50% | 1% | 1 |
| 9 | PROGESTERONE SIDE CHAIN | 1 | 50% | 1% | 1 |
| 10 | ALDOSTERONE ANTAGONIST | 1 | 25% | 1% | 2 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Strategies for Strengthening Patent Protection of Pharmaceutical Inventions in Light of Federal Court Decisions | 2010 | 0 | 4 | 100% |
| PERSPECTIVES IN RECEPTOR-MEDIATED MINERALOCORTICOID HORMONE ACTION | 1994 | 25 | 128 | 16% |
| MINERALOCORTICOID RECEPTOR LIGANDS - BIOCHEMICAL, PHARMACOLOGICAL, AND CLINICAL ASPECTS | 1991 | 36 | 82 | 17% |
| PURIFICATION AND PROPERTIES OF THE MINERALOCORTICOID RECEPTOR WITH THE AID OF SYNTHETIC ANTISTEROIDS | 1991 | 1 | 16 | 69% |
| ROLE OF GLUCOCORTICOID ANTAGONIST RU-486 AND MINERALOCORTICOID ANTAGONIST RU-26752 IN EXPERIMENTAL-HYPERTENSION IN RATS | 1991 | 0 | 6 | 67% |
| General overview of mineralocorticoid hormone action | 1999 | 43 | 417 | 9% |
| RECEPTORS FOR MAMMALIAN STEROID-HORMONES IN MICROBES AND PLANTS | 1993 | 15 | 20 | 15% |
| Tumor necrosis factor as a pharmacological target | 2005 | 31 | 33 | 6% |
| REGULATORY PROTEOLYSIS DURING CORTICOSTEROID HORMONE ACTION | 1984 | 0 | 4 | 100% |
| MODIFICATION OF SHOCK BY THE ANTIGLUCOCORTICOID RU-38486 | 1991 | 1 | 13 | 31% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | INSERM E9912 | 3 | 60% | 1.5% | 3 |
| 2 | U9912 | 1 | 100% | 1.0% | 2 |
| 3 | E 9912 | 1 | 50% | 0.5% | 1 |
| 4 | INSERM E9918 | 1 | 50% | 0.5% | 1 |
| 5 | PENNSYLVANIA BIOTECHNOL | 1 | 50% | 0.5% | 1 |
| 6 | STRUCT BIOL PHARMACOL | 1 | 50% | 0.5% | 1 |
| 7 | XR86 | 1 | 50% | 0.5% | 1 |
| 8 | U86 | 0 | 14% | 1.0% | 2 |
| 9 | CNRSUMR 9955INSERMU414 | 0 | 20% | 0.5% | 1 |
| 10 | BIOPROC DEV GRP | 0 | 17% | 0.5% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000243373 | ESTRADIOL ANALOGUES//9 ANTHRACENEMETHANOL//9 SUBSTITUTED ANTHRACENES |
| 2 | 0.0000155966 | 19 NORDEOXYCORTICOSTERONE//ADRENAL RENAL PORTAL CIRCULATION//19 NORALDOSTERONE |
| 3 | 0.0000135963 | Y 1 ADRENAL CELLS//DOMESTIC MALLARD//ADRENAL CHOLESTEROL |
| 4 | 0.0000129318 | WESTPHALEN REARRANGEMENT//IMIDE REDUCTION//FOSSIL BIOMARKERS |
| 5 | 0.0000125984 | ESTROGEN RECEPTOR ACTIVATION FACTOR//NUCLEAR ESTROGEN RECEPTOR II//NON ACTIVATED ESTROGEN RECEPTOR |
| 6 | 0.0000118939 | HIGH BLOOD P SURE UNIT//ADRENOCORTICOTROPHIC HORMONE//GLUCOCORTICOID INDUCED HYPERTENSION |
| 7 | 0.0000096138 | D HOMOSTEROIDS//FUSED STEROIDS//16 17 SECOSTEROIDS |
| 8 | 0.0000088991 | KETENIMINIUM SALTS//CYCLOBUTENIMINIUMS//CYCLOBUTANONES |
| 9 | 0.0000086716 | AMILORIDE DETERMINATION//FUROSEMIDE DETERMINATION//CHERRY SYRUP |
| 10 | 0.0000082717 | ALDOSTERONE//EPLERENONE//SPIRONOLACTONE |